Read + Share
Amedeo Smart
Independent Medical Education
Tang MW, Van der Tuin D, Aydin M, Heijmans J, et al. Comparison of HiDAC Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome. Eur J Haematol 2024 Dec 26. doi: 10.1111/ejh.14370.PMID: 39726233
Email
LinkedIn
Privacy Policy